Question 1

What is the catalog number for TrkC (Trk-C, Tropomyosin Receptor Kinase C)?

Accepted Answer

The catalog number for TrkC (Trk-C, Tropomyosin Receptor Kinase C) is 217051.

Question 2

What sizes are available for TrkC (Trk-C, Tropomyosin Receptor Kinase C)?

Accepted Answer

TrkC (Trk-C, Tropomyosin Receptor Kinase C) is available in the following size(s): 100 µg.

Question 3

Is TrkC (Trk-C, Tropomyosin Receptor Kinase C) in stock?

Accepted Answer

TrkC (Trk-C, Tropomyosin Receptor Kinase C) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What should I do if I need to report a performance issue with a specific lot of this product?

Accepted Answer

Provide the catalogue number, product name, lot number, and your experimental results to our technical support team. They’ll investigate and, if needed, escalate to the manufacturer, provided the product was used before expiry and stored correctly.

Question 5

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

Question 6

Can I get a trial-size or discounted first order of this product?

Accepted Answer

We don’t generally offer free samples, but trial discounts in exchange for feedback and validation results are almost always possible. Contact us with your intended application to arrange one.

TrkC (Trk-C, Tropomyosin Receptor Kinase C)

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

NME1 / nm23-H1 / NDPK-A (Suppressor of Metastasis) (CPTC-NME1-2), CF568 conjugate, 0.1mg/mL

Anti-Matrix metalloproteinase-24 MMP24 Antibody Picoband®, FITC Conjugate

Histone H1 (Nuclear Marker) (r1415-1), CF488A conjugate, 0.1mg/mL

Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker) (KRT19/1959R), CF647 conjugate, 0.1mg/mL

ICOS-L / ICOS Ligand / B7RP-1 (Immuno-Oncology Target) (ICOSL/3260), 0.2mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2745), CF640R conjugate, 0.1mg/mL